Refractory metastatic colorectal cancer: challenges and solutions during the COVID-19 pandemic

Refractory metastatic colorectal cancer: challenges and solutions during the COVID-19 pandemic

Colorectal cancer (CRC) is one of the leading cancers in terms of prevalence and mortality. Almost 1/4 of patients with CRC have metastases at the initial presentation. The survival rate of this group of patients remains low. With the onset of the COVID-19 pandemic, cancer patients have faced diffic...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Marina I. Sekacheva, Anastasia S. Fatyanova, Daur A. Meretukov, Angelina V Zhilenkova, Aleksandr S. Rusanov, Aleksandr A. Rozhkov, Anastasiia A. Guryanova, Nikolay N. Bagmet
Format: article
Langue:RU
Publié: IP Habib O.N. 2021
Sujets:
colorectal cancer
covid-19
chemotherapy
targeted therapy
regorafenib
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Accès en ligne:https://doaj.org/article/74b49f25f4074c698a61ce570af6f103
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Internet

https://doaj.org/article/74b49f25f4074c698a61ce570af6f103

Documents similaires